65,437 trials
Myeloid Hematologic Malignancy · Lymphoid Hematologic Malignancy
Primary: Number of Patients Absence of Grade II-IV aGVHD or Chronic GVHD Diagnostic Features — 13; 5 Participants
Swallowing Disorder · Respiratory Insufficiency
Primary: Swallow Frequency Recorded by Surface Electromyography (sEMG) — 1.12; 1.13; 3.91; 1.01 number of swallows
Diabetes Type 2 · Dementia
Primary: Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET)--Whole Brain — 12.28; 11.75 micromoles/min/100g tissue
Lewy Body Disease · Parkinson Disease
Primary: Percent Change From Baseline in Cerebrospinal Fluid (CSF) Cyclic Guanosine Monophosphate (cGMP) at Week 9 — 230.412; 250.434; 186.869; 362.519 Percent Change in CSF…
Obesity
Primary: Patient Engagement (Patient Activation Measure) — 70.2; 67.6; 72.7; 70.3 score on a scale
Neurogenic Orthostatic Hypotension · Multiple System Atrophy (MSA) With Orthostatic Hypotension · Pure Autonomic Failure
Primary: Part A: Change From Time-matched Placebo in Seated Systolic Blood Pressure (SBP) — 0.2; -1.8; -3.4; -2.9 millimeter of mercury (mmHg)
Orthostatic Hypotension · Idiopathic Parkinson Disease
Primary: Orthostatic Hypotension Questionnaire (OHQ) Score — 4.6 score on a scale
Rotator Cuff Tear Repair Anchors
Primary: American Shoulder and Elbow Surgeons( ASES)-Shoulder Form — 30; 30 score on a scale
Venous Thromboembolism · Ovarian Cancer
Primary: Number of Participants Experiencing a Venous Thromboembolism — 4 Participants
High Risk Pregnancy · Cesarean Wound Disruption With Postnatal Complication
Primary: Wound Complication — 13; 14 Participants
COVID-19
Primary: Evaluate the Ability of Inhaled Nasal Sodium Pyruvate to Change COVID-19 Viral Titers. — 5.61; 6.57; 4.67; 5.86 Log10 viral RNA copies — p=0.0197
Glaucoma
Primary: Qualitative B-Scan Assessment — 2.78; 2.77; 2.08 Mean score on a scale (0-3)
Refractive Errors · Ametropia · Astigmatism
Primary: Least Squares Mean Distance VA (logMAR) With Study Lenses — -0.08; -0.07 logMAR
Muscular Dystrophy, Duchenne
Primary: Change From Baseline to Week 12 in the Lower Leg Composite of the MRI T2 Relaxation Time (LLC5-T2) - Part B — 2.04; 1.26; 0.34; 0.35 msec
Stroke · Stroke, Acute · Brain Injury, Acute
Primary: Shift in Modified Rankin Scale (mRS) — 1; 1 score on a scale — p=0.71